ClinicalTrials.Veeva

Menu

Effect of Variceal Eradication on Portal Circulation

A

Assiut University

Status

Not yet enrolling

Conditions

Portosystemic Collateral Veins

Treatments

Radiation: Abdominal computed tomography with angiography.

Study type

Observational

Funder types

Other

Identifiers

NCT04538209
portal circulation assessment

Details and patient eligibility

About

Study the effect of variceal eradication on portal circulation, liver stiffness and Child-Pugh and MELD scores in patients with liver cirrhosis.

Full description

Portosystemic collateral circulation is a consequence of portal hypertension, which occurs in chronic liver disease and is responsible for numerous complications.

Gastric and oesophageal varices are two of common portosystemic collaterals, patients usually presented with hematemesis, melena, or both, ultimately 20% is the mortality during the first attack.

Although both band ligation and sclerotherapy are effective modalities of treatment in controlling acute variceal bleeding, in preventing future variceal bleeding as well as in eradicating varices with very few complications , their effects on portal circulation have raised concerns among hepatologist.

Information about collateral pathways is especially relevant when interventional procedures or surgery is indicated because inadvertent distribution of these vessels can cause significant bleeding.

Few studies pointed on development of new portosystemic collaterals post variceal eradication depending on abdominal computed tomography (CT ) compared to pre-variceal eradication as showed paraoesophageal varices, retro-gastric varices not visualized with endoscopy ,or large deep gastric collaterals that may increase risk for rebleeding.

Also, liver stiffness measurement and indirect markers of portal hypertension have been correlated with the severity of portal hypertension and have been used to predict the presence of varices, and there is rising question what about effect of variceal eradication on liver stiffness.

The Child-Pugh and MELD scores were significantly higher for patients with gastric variceal bleeding , and the question here is variceal eradication can improve Child-Pugh and MELD scores or there is no effect.

Enrollment

52 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Age between 18 and 70 years old.

    • Patient with documented liver cirrhosis undergoing either primary or secondary prophylactic variceal eradication.
    • Liver cirrhosis with Child-Pugh score A and B.

Exclusion criteria

  • • Age less than 18 years.

    • Have contraindications to computed abdominal CT-angiography (e.g. allergy to all suitable contrast agents, renal failure).
    • Patients with history of recent significant bleeding varices.
    • Previous history of variceal ligation, sclerotherapy, and TIPS operation.
    • Patients with isolated gastric varices.
    • Patients with HCC or other malignancies.
    • End-stage liver disease (Child score more than 9).
    • Patients with malignant portal vein thrombosis.
    • Patients with non-cirrhotic portal hypertension.
    • Patients refuse to participate in the study.

Trial design

52 participants in 1 patient group

canditates for variceal eradication
Description:
patients with documented liver cirrhosis (Based on clinical, laboratory and ultrasonographic findings) undergoing either primary or secondary prophylaxis variceal eradication at endoscopy unit of El-Rajhi hospital, Assuit University
Treatment:
Radiation: Abdominal computed tomography with angiography.

Trial contacts and locations

0

Loading...

Central trial contact

Esraa Swifee, M.A gastroenterology

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems